# Atypical lung carcinoid with prominent mucinous stroma: unusual pathologic finding in pulmonary carcinoid

**Authors:** Ghaida S AlSugair, Wajd A Althakfi

PMC · DOI: 10.1093/omcr/omag020 · Oxford Medical Case Reports · 2026-03-23

## TL;DR

A rare lung tumor case with mucin-rich features is described, highlighting the importance of recognizing this variant to avoid misdiagnosis.

## Contribution

The paper presents a unique case of atypical lung carcinoid with prominent mucinous stroma, emphasizing its diagnostic challenges.

## Key findings

- A 34-year-old female was diagnosed with an atypical carcinoid featuring a prominent mucinous stroma.
- The tumor exhibited organoid, trabecular, and pseudopapillary histologic patterns with positive immunohistochemical markers.
- The case underscores the need for careful evaluation to distinguish this variant from other mucin-producing lung tumors.

## Abstract

Background: Atypical carcinoids (ACs) are uncommon neuroendocrine tumors of the lung, and the presence of a prominent mucinous stroma is an exceptionally rare feature that may complicate diagnosis. Highlighting such variants is important for avoiding misclassification with mucin-producing pulmonary tumors. Case Presentation: A 34-year-old nonsmoking female presented with mild chest pain, minimal cough, and night sweats. Imaging revealed a well-circumscribed right middle-lobe lesion measuring 4.1 cm, and bronchoscopy showed a white-tan, fleshy mass filling the bronchial lumen. Pathology Findings: Histologic examination demonstrated a well-defined neoplasm with organoid, trabecular, follicular, pseudopapillary, and solid patterns and striking mucinous stromal change. Immunohistochemical staining was positive for CK AE1/AE3, synaptophysin (diffuse), chromogranin (diffuse), and TTF1, and negative for CK7, CK20, and CDX2. Focal necrosis and a mitotic rate of up to 5/2 mm2 supported the diagnosis of AC. Conclusion: This case represents a rare morphologic variant of AC distinguished by a prominent mucinous stroma, a feature that may obscure the diagnosis by simulating other mucin-producing lung tumors. Recognizing this uncommon pattern is crucial, as it directly impacts diagnostic accuracy and subsequent clinical decision-making.

## Linked entities

- **Proteins:** TTF1 (transcription termination factor 1), KRT7 (keratin 7), KRT20 (keratin 20), CDX2 (caudal type homeobox 2)
- **Diseases:** lung tumor (MONDO:0021117)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}, mucin [NCBI Gene 100508689], SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}
- **Diseases:** necrosis (MESH:D009336), cough (MESH:D003371), neoplasm (MESH:D009369), chest pain (MESH:D002637), AC (MESH:D055577), mucinous (MESH:D002288), lung tumors (MESH:D008175), ACs (MESH:D002276), neuroendocrine tumors (MESH:D018358)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13007866/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13007866/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC13007866/full.md

---
Source: https://tomesphere.com/paper/PMC13007866